Live Breaking News & Updates on Potential Oral Substrate Reduction Therapy

The FTC announced yesterday that it would seek to block Sanofi’s proposed exclusive license agreement with Maze Therapeutics, having concluded that the transaction would “eliminate a. ....

Genyzme Corporation , M Maze Partnership , Maze Therapeutics , While Sanofi , Block Sanofi , Rare Disease Drug , Threatens Sanofi , Proposed License Agreement With Maze Therapeutics , Pharmaceutical Mergers , Merger Guidelines , Sherman Act , Sanofi Bets , Sanofi Deepens Pompe Disease Focus , Maze Partnership , Federal Trade Commission , Preliminary Injunction Pursuant , Federal Trade Commission Act , Maze Therapeutics Announces , Block Collaboration , License Agreement , Sanofi Regarding , Potential Oral Substrate Reduction Therapy , Pompe Disease , Pompe Drug ,